Page 1 of Clinical Trials for Erlotinib Hydrochloride, 634 Total Matches
- 1Active, not recruitingLast Updated: April 25, 2012Condition(s): Adenocarcinoma of the Esophagus; Adenocarcinoma of the Gastroesophageal Junction; Adenocarcinoma of the Stomach; Squamous Cell Carcinoma of the Esophagus; Stage II Esophageal Cancer; Stage II Gastric Cancer; Stage III Esophageal Cancer; Stage III Gastric Cancer
- 2Active, not recruitingLast Updated: March 15, 2012Condition(s): Transitional Cell Carcinoma
- 3Active, not recruitingLast Updated: May 16, 2012Condition(s): Pancreatic Cancer; Pancreatic Adenocarcinoma
- 4Active, not recruitingLast Updated: February 10, 2012Condition(s): Non-small Cell Lung Cancer; Brain Cancer
- 5Active, not recruitingLast Updated: March 26, 2012Condition(s): Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
- 6Active, not recruitingLast Updated: March 13, 2012Condition(s): Head and Neck Cancer
- 7RecruitingLast Updated: April 27, 2012Condition(s): Squamous Cell Carcinoma of the Skin; Stage I Squamous Cell Carcinoma of the Hypopharynx; Stage I Squamous Cell Carcinoma of the Larynx; Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage I Squamous Cell Carcinoma of the Oropharynx; Stage I Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage I Verrucous Carcinoma of the Larynx; Stage I Verrucous Carcinoma of the Oral Cavity; Stage II Squamous Cell Carcinoma of the Hypopharynx; Stage II Squamous Cell Carcinoma of the Larynx; Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage II Squamous Cell Carcinoma of the Oropharynx; Stage II Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage II Verrucous Carcinoma of the Oral Cavity
- 8TerminatedLast Updated: December 9, 2011Condition(s): Lung Cancer; Metastatic Cancer
- 9Enrolling by invitationLast Updated: February 29, 2012Condition(s): Ependymoma
- 10Active, not recruitingLast Updated: January 20, 2012Condition(s): Head and Neck Squamous Cell Carcinoma
- 11Active, not recruitingLast Updated: September 9, 2011Condition(s): Recurrent Non-small Cell Lung Cancer; Stage IIIB Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer
- 12CompletedLast Updated: May 25, 2011Condition(s): Lung Adenocarcinoma
- 13CompletedLast Updated: May 9, 2012Condition(s): Lung Cancer
- 14Not yet recruitingLast Updated: March 30, 2012Condition(s): Non Small Cell Lung Cancer
- 15CompletedLast Updated: May 19, 2010Condition(s): Breast Cancer
- 16Active, not recruitingLast Updated: May 16, 2012Condition(s): Non-Small Cell Lung Cancer; Lung Cancer
- 17RecruitingLast Updated: May 16, 2012Condition(s): Non Small Cell Lung Cancer; NSCLC
- 18RecruitingLast Updated: May 22, 2012Condition(s): Non-Small Cell Lung Cancer (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy
- 19Active, not recruitingLast Updated: October 17, 2011Condition(s): Brain and Central Nervous System Tumors
- 20TerminatedLast Updated: February 10, 2012Condition(s): Breast Cancer
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Erlotinib+Hydrochloride
